« Back to Record
Citation APA

Keyaerts, M., Simon, P., Schallier, D., Fontaine, C., Vaneycken, I., Vanhove, C., De Greve, J., Lamote, J., Caveliers, V., Lahoutte, T., Xavier, C., Heemskerk, J., Devoogdt, N., Everaert, H., Ackaert, C., Vanhoeij, M., Duhoux, F. F., & Gevaert, T. (2016). Phase i study of 68Ga-HER2-Nanobody for PET/CT assessment of HER2 expression in breast carcinoma. The Journal of nuclear medicine, 57(1), 27-33. doi:10.2967/jnumed.115.162024


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231231

Keyaerts, M., Simon, P., Schallier, D., Fontaine, C., Vaneycken, I., Vanhove, C., De Greve, J., Lamote, J., Caveliers, V., Lahoutte, T., Xavier, C., Heemskerk, J., Devoogdt, N., Everaert, H., Ackaert, C., Vanhoeij, M., Duhoux, F. F., & Gevaert, T. (2016). Phase i study of 68Ga-HER2-Nanobody for PET/CT assessment of HER2 expression in breast carcinoma. The Journal of nuclear medicine, 57(1), 27-33. doi:10.2967/jnumed.115.162024